Trial · NCT02914314
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Core Phase (Up to 20 Weeks) | STARTED | Cohort 1, Age >=1 to <=6 Months: Perampanel | 4 | |
| Core Phase (Up to 20 Weeks) | STARTED | Cohort 2, Age >6 to <=12 Months: Perampanel | 5 | |
| Core Phase (Up to 20 Weeks) | STARTED | Cohort 3, Age >12 to <24 Months: Perampanel | 9 | |
| Core Phase (Up to 20 Weeks) | STARTED | Cohort 4, Age >=24 to <48 Months: Perampanel | 3 | |
| Core Phase (Up to 20 Weeks) | Participants Who Did Not Take EIAED | Cohort 1, Age >=1 to <=6 Months: Perampanel | 4 | |
| Core Phase (Up to 20 Weeks) | Participants Who Did Not Take EIAED | Cohort 2, Age >6 to <=12 Months: Perampanel | 3 | |
| Core Phase (Up to 20 Weeks) | Participants Who Did Not Take EIAED | Cohort 3, Age >12 to <24 Months: Perampanel | 5 | |
| Core Phase (Up to 20 Weeks) | Participants Who Did Not Take EIAED | Cohort 4, Age >=24 to <48 Months: Perampanel | 1 | |
| Core Phase (Up to 20 Weeks) | Participants Who Took EIAED | Cohort 1, Age >=1 to <=6 Months: Perampanel | 0 | |
| Core Phase (Up to 20 Weeks) | Participants Who Took EIAED | Cohort 2, Age >6 to <=12 Months: Perampanel | 2 | |
| Core Phase (Up to 20 Weeks) | Participants Who Took EIAED | Cohort 3, Age >12 to <24 Months: Perampanel | 4 | |
| Core Phase (Up to 20 Weeks) | Participants Who Took EIAED | Cohort 4, Age >=24 to <48 Months: Perampanel | 2 | |
| Core Phase (Up to 20 Weeks) | COMPLETED | Cohort 1, Age >=1 to <=6 Months: Perampanel | 4 | |
| Core Phase (Up to 20 Weeks) | COMPLETED | Cohort 2, Age >6 to <=12 Months: Perampanel | 5 | |
| Core Phase (Up to 20 Weeks) | COMPLETED | Cohort 3, Age >12 to <24 Months: Perampanel | 8 | |
| Core Phase (Up to 20 Weeks) | COMPLETED | Cohort 4, Age >=24 to <48 Months: Perampanel | 1 | |
| Core Phase (Up to 20 Weeks) | NOT COMPLETED | Cohort 1, Age >=1 to <=6 Months: Perampanel | 0 | |
| Core Phase (Up to 20 Weeks) | NOT COMPLETED | Cohort 2, Age >6 to <=12 Months: Perampanel | 0 | |
| Core Phase (Up to 20 Weeks) | NOT COMPLETED | Cohort 3, Age >12 to <24 Months: Perampanel | 1 | |
| Core Phase (Up to 20 Weeks) | NOT COMPLETED | Cohort 4, Age >=24 to <48 Months: Perampanel | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02914314/flow